| pubmed-article:9777081 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9777081 | lifeskim:mentions | umls-concept:C0039240 | lld:lifeskim |
| pubmed-article:9777081 | lifeskim:mentions | umls-concept:C0001443 | lld:lifeskim |
| pubmed-article:9777081 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:9777081 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:9777081 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9777081 | pubmed:dateCreated | 1998-12-11 | lld:pubmed |
| pubmed-article:9777081 | pubmed:abstractText | The efficacy, safety and diagnostic usefulness of adenosine in the treatment of supraventricular tachycardia in children were prospectively studied over a 2-year period. Only patients who were stable and without hypotension were included. Adenosine was given at a dose of 0.1 mg/kg and increased to 0.2 mg/kg for the second and third doses if there was no response. Adenosine was used on 5 occasions in 5 patients. Adenosine was found to be effective in terminating supraventricular tachycardia in all 5 patients; 4 responded to a dose of 0.2 mg/kg while 1 responded to 0.1 mg/kg. Wolff-Parkinson White Syndrome was detected in 2 patients after termination of supraventricular tachycardia. Transient hypotension was noted in 1 patient lasting 45 seconds with no haemodynamic consequences. Two patients had transient ventricular ectopics lasting 3 to 5 seconds. One out of 3 patients who were old enough to report side-effects, experienced chest discomfort and dizziness lasting 5 seconds. All side-effects were transient and mild. We concluded that adenosine is effective and safe in terminating supraventricular tachycardia in children after vagal manoeuvres have failed. | lld:pubmed |
| pubmed-article:9777081 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9777081 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9777081 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9777081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9777081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9777081 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9777081 | pubmed:month | May | lld:pubmed |
| pubmed-article:9777081 | pubmed:issn | 0304-4602 | lld:pubmed |
| pubmed-article:9777081 | pubmed:author | pubmed-author:ChaoHH | lld:pubmed |
| pubmed-article:9777081 | pubmed:author | pubmed-author:WongK YKY | lld:pubmed |
| pubmed-article:9777081 | pubmed:author | pubmed-author:KonKK | lld:pubmed |
| pubmed-article:9777081 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9777081 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:9777081 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9777081 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9777081 | pubmed:pagination | 363-5 | lld:pubmed |
| pubmed-article:9777081 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:meshHeading | pubmed-meshheading:9777081-... | lld:pubmed |
| pubmed-article:9777081 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9777081 | pubmed:articleTitle | Five paediatric case reports of the use of adenosine in supraventricular tachycardia. | lld:pubmed |
| pubmed-article:9777081 | pubmed:affiliation | Department of Paediatrics, Singapore General Hospital. | lld:pubmed |
| pubmed-article:9777081 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9777081 | pubmed:publicationType | Case Reports | lld:pubmed |
